Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances

References

• SamterMBeersRFJrIntolerance to aspirin. Clinical studies and consideration of its pathogenesisAnn Intern Med19686859759835646829
   PubMed Web of Science ®Google Scholar
• RajanJPWineingerNEStevensonDDWhiteAAPrevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literatureJ Allergy Clin Immunol20151353676.e1681.e125282015
   PubMed Web of Science ®Google Scholar
• SzczeklikANizankowskaEClinical features and diagnosis of aspirin induced asthmaThorax200055S42S4410992556
   PubMed Web of Science ®Google Scholar
• VallyHTaylorMLThompsonPJThe prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patientsThorax20025756957412096197
   PubMed Web of Science ®Google Scholar
• MasciaKBorishLPatrieJHuntJPhillipsCDSteinkeJWChronic hyperplastic eosiniphilic sinusistis as a predictor of aspirin-exacerbated respiratory diseaseAnn Allergy Asthma Immunol20059465265715984597
   PubMed Web of Science ®Google Scholar
• SteinkeJWBorishLFactors driving the aspirin exacerbated respiratory disease phenotypeAm J Rhinol Allergy2015291354025590316
   PubMed Web of Science ®Google Scholar
• PayneSCEarlySBHuyettPHanJKBorishLSteinkeJWEvidence for distinct histologic profile of nasal polyps with and without eosinophiliaLaryngoscope2011121102262226721898422
   PubMed Web of Science ®Google Scholar
• BachertCWagenmannMHauserURudackCIL-5 synthesis is upregulated in human nasal polyp tissueJ Allergy Clin Immunol1997998378429215253
   PubMed Web of Science ®Google Scholar
• SampsonAPCowburnASSladekKProfound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patientsInt Arch Allergy Immunol19971133553579130576
   PubMed Web of Science ®Google Scholar
• SteinkeJWLiuLHuyettPNegriJPayneSCBorishLProminent role of interferon-γ in aspirin-exacerbated respiratory diseaseJ Allergy Clin Immunol2013132856.e3865.e323806637
   PubMed Web of Science ®Google Scholar
• CowburnASSladekKSojaJOverexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthmaJ Clin Invest19981018348469466979
   PubMed Web of Science ®Google Scholar
• Perez-NovoCAWateletJBClaeysCvan CauwenbergePBachertCProstaglandin, leukotiene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposisJ Allergy Clin Immunol20051151189119615940133
   PubMed Web of Science ®Google Scholar
• SchmidMGodeUSchaferDWigandMEArachidonic acid metabolism in nasal tissue and peripheral blood cells in aspirin intolerant asthmaticsActa Otolaryngol199911927728010320091
   PubMed Web of Science ®Google Scholar
• PicadoCFernandez-MorataJCJuanMCyclooxygenase-2 mRNA is down expressed in nasal polyps from aspirin-sensitive asthmaticsAm J Respir Crit Care Med199916029129610390414
   PubMed Web of Science ®Google Scholar
• GosepathJBriegerJMannWJNew immunohistologic findings on the differential role of cyclooxygenase 1 and cyclooxygenase 2 in nasal polposisAm J Rhinol20051911111615921208
   PubMedGoogle Scholar
• MurakamiMNakashimaKKameiDCellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2J Biol Chem200327839379373794712835322
   PubMed Web of Science ®Google Scholar
• SturmEMSchratlPSchuligoiRProstaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptorsJ Immunol2008181107273728318981149
   PubMed Web of Science ®Google Scholar
• KayLJYeoWWPeachellPTProstaglandin E2 activated EP2 receptors to inhibit human lung mast degranulationBr J Pharmacol200614770771316432506
   PubMed Web of Science ®Google Scholar
• SteinkeJWEditorial: Yin-Yang of EP receptor expressionJ Leukoc Biol20129261129113123204260
   PubMed Web of Science ®Google Scholar
• SestiniPArmettiLGambaroGInhaled PgE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthmaAm J Respir Crit Care Med19961535725758564100
   PubMed Web of Science ®Google Scholar
• FengCBellerEMBaggaSBoyceJAHuman mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responsesBlood20061073243325016357326
   PubMed Web of Science ®Google Scholar
• SteinkeJWBradleyDArangoPCytseinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthmaJ Allergy Clin Immunol200311134234912589355
   PubMed Web of Science ®Google Scholar
• BrocklehurstWEThe release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shockJ Physiol196015141643513804592
   PubMed Web of Science ®Google Scholar
• ChristiePETagariPFord-HutchinsonAWUrinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjectsAm Rev Respir Dis1991143102510291850964
   PubMed Web of Science ®Google Scholar
• SladekKSzczeklikACysteinyl leukotrienes overproduction and mast cell activation in aspirn-provoked bronchospasm in asthmaEur Respir J199363913998386106
   PubMed Web of Science ®Google Scholar
• AustenKFMaekawaAKanaokaYBoyceJAThe leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implicationsJ Allergy Clin Immunol2009124340641419647860
   PubMed Web of Science ®Google Scholar
• ArmJPO’HickeySSpurBWLeeTHAirway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthmaAm Rev Respir Dis19891401481532546469
   PubMed Web of Science ®Google Scholar
• ChristiePESchmitz-SchumannMSpurBWLeeTHAirway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjectsEur Respir J19936146814738112440
   PubMed Web of Science ®Google Scholar
• LaitinenLALaitinenAHaahtelaTVilkkaVSpurBWLeeTHLeukotriene E4 and granulocytic infiltration into asthmatic airwaysLancet19933419899908096945
   PubMed Web of Science ®Google Scholar
• CorriganCMallettKYingSExpression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitisJ Allergy Clin Immunol2005115231632215696087
   PubMed Web of Science ®Google Scholar
• SousaARParikhAScaddingGCorriganCJLeeTHLeukotriene-receptor expression on nasal mucosal inflammatory cells in asprin-sensitive rhinosinusitisN Engl J Med20023471493149912421891
   PubMed Web of Science ®Google Scholar
• LynchKRO’NeillGPLiuQCharacterization of the human cysteinyl leukotriene CysLT1 receptorNature1999399673878979310391245
   PubMed Web of Science ®Google Scholar
• ChristiePESmithCMLeeTHThe potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthmaAm Rev Respir Dis19911449579581928974
   PubMed Web of Science ®Google Scholar
• DahlenBTreatment of aspirin-intolerant asthma with antileukotrienesAm J Respir Crit Care Med2000161SupplS137S14110673243
   PubMed Web of Science ®Google Scholar
• ParuchuriSTashimoHFengCLeukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptorJ Exp Med2009206112543255519822647
   PubMed Web of Science ®Google Scholar
• KanaokaYMaekawaAAustenKFIdentification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligandJ Biol Chem201328816109671097223504326
   PubMed Web of Science ®Google Scholar
• MaekawaAKanaokaYXingWAustenKFFunctional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptorsProc Natl Acad Sci U S A200810543166951670018931305
   PubMed Web of Science ®Google Scholar
• KowalskiMLGrzegorczykJPawliczakRKornatowskiTWagrowska-DanilewiczMDanilewiczMDecreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivityAllergy200257649350012028114
   PubMed Web of Science ®Google Scholar
• VargaEMJacobsonMRMasuyamaKInflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitisEur Respir J199914361061510543283
   PubMed Web of Science ®Google Scholar
• StevensWWOcampoCJBerdnikovsSCytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory diseaseAm J Respir Crit Care Med2015192668269426067893
   PubMed Web of Science ®Google Scholar
• ShomeGPTarboxJShearerMKennedyRCytokine expression in peripheral blood lymphocytes before and after aspirin desensitization in aspirin-exacerbated respiratory diseaseAllergy Asthma Proc200728670671018201436
   PubMed Web of Science ®Google Scholar
• HsiehFHLamBKPenroseJFAustenKFBoyceJAT helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C4 synthase expression by interleukin 4J Exp Med200119312313311136826
   PubMed Web of Science ®Google Scholar
• SteinkeJWCulpJAKropfEBorishLModulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: possible role in therapeutic benefit associated with aspirin desensitizationJ Allergy Clin Immunol20091244724.e4730.e419767084
   PubMed Web of Science ®Google Scholar
• ZhangNVan ZeleTPerez-NovoCDifferent types of T-effector cells orchestrate mucosal inflammation in chronic sinus diseaseJ Allergy Clin Immunol2008122596196818804271
   PubMed Web of Science ®Google Scholar
• LiuTKanaokaYBarrettNAAspirin-exacerbated respiratory disease involves a cysteinyl leukotriene-driven IL-33-mediated mast cell activation pathwayJ Immunol201519583537354526342029
   PubMed Web of Science ®Google Scholar
• GriseriTArnoldICPearsonCGranulocyte macrophage colony-stimulating factor-activated eosinophils promote interleukin-23 driven chronic colitisImmunity201543118719926200014
   PubMed Web of Science ®Google Scholar
• LamasSMichelTBrennerBMMarsdenPANitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-alphaAm J Physiol19912614 Pt 1C634C6411656767
   PubMed Web of Science ®Google Scholar
• TakabayashiTKatoAPetersATExcessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expressionAm J Respir Crit Care Med20131871495723155140
   PubMed Web of Science ®Google Scholar
• LaidlawTMKidderMSBhattacharyyaNCysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytesBlood2012119163790379822262771
   PubMed Web of Science ®Google Scholar
• StankovicKMGoldszteinHRehDDPlattMPMetsonRGene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthmaLaryngoscope2008118588188918391768
   PubMed Web of Science ®Google Scholar
• KimMAIzuharaKOhtaSAssociation of serum periostin with aspirin-exacerbated respiratory diseaseAnn Allergy Asthma Immunol2014113331432025037608
   PubMed Web of Science ®Google Scholar
• ParulekarADAtikMAHananiaNAPeriostin, a novel biomarker of TH2-driven asthmaCurr Opin Pulm Med2014201606524247042
   PubMed Web of Science ®Google Scholar
• ShinSParkJSKimYJOhTAnSParkCSDifferential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERDMol Genet Genomics2012287536137122457146
   PubMed Web of Science ®Google Scholar
• KimJHParkBLCheongHSGenome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthmaPLoS One2010511e1381821072201
   PubMed Web of Science ®Google Scholar
• ParkBLKimTHKimJHGenome-wide association study of aspirin-exacerbated respiratory disease in a Korean populationHum Genet2013132331332123180272
   PubMed Web of Science ®Google Scholar
• KimSHChoBYChoiHThe SNP rs3128965 of HLA-DPB1 as a genetic marker of the AERD phenotypePLoS One2014912e11122025536158
   PubMed Web of Science ®Google Scholar
• DekkerJWNizankowskaESchmitz-SchumannMAspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypesClin Exp Allergy19972755745779179433
   PubMed Web of Science ®Google Scholar
• DahlenSEMalmstromKNizankowskaEImprovement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trialAm J Respir Crit Care Med2002165191411779723
   PubMed Web of Science ®Google Scholar
• DahlenBNizankowskaESzczeklikABenefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmaticsAm J Respir Critc Care Med199815711871194
   PubMed Web of Science ®Google Scholar
• KubavatAHKhippalNTakSA randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthmaAm J Ther201320215416222926233
   PubMed Web of Science ®Google Scholar
• TaVWhiteAASurvey-defined patient experiences with aspirin-exacerbated respiratory diseaseJ Allergy Clin Immunol Pract20153571171825858054
   PubMed Web of Science ®Google Scholar
• WuXHongHZuoKExpression of leukotriene and its receptors in eosinophilic chronic rhinosinusitis with nasal polypsInt Forum Allergy Rhinol201661758126332237
   PubMed Web of Science ®Google Scholar
• Mrowka-KataKCzeciorEKataDNamyslowskiGDziechciarz-WerbowskaJSowaPCurrent view on nasal polyps management in Samter’s triad patientsOtolaryngol Pol201266637337823200555
   PubMedGoogle Scholar
• SweetJMStevensonDDSimonRAMathisonDALong-term effects of aspirin desensitization – treatment for aspirin-sensitive rhinosinusitis-asthmaJ Allergy Clin Immunol19908559652299107
   PubMed Web of Science ®Google Scholar
• StevensonDDSimonRASelection of patients for aspirin desensitization treatmentJ Allergy Clin Immunol200611880180417030229
   PubMed Web of Science ®Google Scholar
• StevensonDDHankammerMAMathisonDAChristiansenSCSimonRAAspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomesJ Allergy Clin Immunol1996987517588876550
   PubMed Web of Science ®Google Scholar
• PerezGMMeloMKeeganADZamoranoJAspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6J Immunol200216831428143411801685
   PubMed Web of Science ®Google Scholar
• KatialRKStrandMPrasertsuntarasaiTLeungRZhengWAlamRThe effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseasesJ Allergy Clin Immunol2010126473874420728206
   PubMed Web of Science ®Google Scholar
• GevaertPVan BruaeneNCattaertTMepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposisJ Allergy Clin Immunol20111285989995.e1e821958585
   PubMed Web of Science ®Google Scholar
• WenzelSFordLPearlmanDDupilumab in persistent asthma with elevated eosinophil levelsN Eng J Med20133682624552466
   PubMed Web of Science ®Google Scholar
• BoboleaIBarrancoPFiandorACabanasRQuirceSOmalizumab: a potential new therapeutic approach for aspirin-exacerbated respiratory diseaseJ Investig Allergol Clin Immunol2010205448449
   PubMed Web of Science ®Google Scholar
• YalcinADUcarSGumusluSStraussLGEffects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter’s syndrome: 36 months follow-upImmunopharmacol Immunotoxicol201335452452723841472
   PubMed Web of Science ®Google Scholar
• BergmannKCZuberbierTChurchMKOmalizumab in the treatment of aspirin-exacerbated respiratory diseaseJ Allergy Clin Immunol Pract20153345946025648572
   PubMed Web of Science ®Google Scholar